Every buyer promises autonomy. We show you who delivers.
We represent dermatology practice owners who want efficient, sophisticated guidance on market value and buyer quality. We create competitive processes that separate genuine partnerships from empty promises.
What buyers look for in dermatology practices
Buyers care about your aesthetic versus medical revenue split, Mohs capabilities, provider leverage, and EBITDA margins. But headlines don't tell you which buyers will actually pay premium multiples for what you've built versus which ones will lowball you and force volume increases post-close.
We identify the difference, then create competition to prove it.
Sandy Stewart
Jennifer Walden MD
Lauren Olson
Dr. Chynna Steele Johnson
150+
Years of healthcare, M&A, and banking expertise
23%
Average price increase
$2-30M
Typical M&A client revenues
About Practice Transitions Group
Why dermatology practices work with us
You're negotiating alone against buyers who do this every day. We create competition. One unsolicited offer becomes multiple competing offers, driving better terms and higher valuations. We move fast because you don't have patience for drawn-out processes.
We vet buyers for quality. Not all private equity groups understand dermatology operations or respect clinical standards. Some destroyed practices in the first consolidation wave. We identify which buyers have genuine expertise and track records that prove it, then position your practice to attract premium offers from the right groups.
We negotiate beyond the purchase price. Post-transaction compensation, earnout structures, clinical autonomy provisions, and equity terms matter as much as the headline multiple. Many dermatologists don't realize they're taking a pay cut until after they sign. We prevent that by identifying aggressive deal terms before you're locked in.
"Thomas and his team managed the entire sale process from start to finish. They were very thorough and professional. The process is long and complicated with many moving parts and phases. Thomas's experience and expertise were absolutely essential in navigating the process. He was an advisor, guide, and hand-holder along the way. I would use this group again in a heartbeat."
Dr. Steele Johnson
Steele Dermatology
Dermatology Seller FAQs
We work exclusively for practice owners and never take fees from buyers. This means we have complete alignment with your interests. We're not incentivized to push you toward any particular buyer or deal. Our only job is to maximize your outcome and protect you throughout negotiations.
This is common. Most dermatology practice owners come to us after receiving an unsolicited offer and wanting to know if it's competitive. We evaluate your current offer, identify any problematic terms, and approach other qualified buyers to create competition. Creating a competitive process typically improves both purchase price and deal terms, even when you already have an offer. We also help you understand how the post-transaction compensation structure will actually affect your take-home income.
We start by analyzing your financials to determine normalized EBITDA, which accounts for add-backs like owner compensation, retirement plan contributions, and one-time expenses. Many dermatology practices have complex financial structures designed for tax efficiency, so we help translate these for buyers.
From there, we assess market multiples based on your aesthetic versus medical revenue split, procedural capabilities like Mohs surgery, provider structure and productivity distribution, and payor mix. We also evaluate qualitative factors like your high-end market positioning, staff stability, and whether you have key person risk. This gives us a realistic valuation range that cuts through the inflated numbers you've heard from colleagues.
We work with established dermatology practices that typically have $2.5M+ in revenue, strong provider leverage, and solid EBITDA margins. Practices with a balanced mix of medical and cosmetic services, procedural capabilities like Mohs surgery or injectables, multiple locations, or specialized expertise are particularly attractive to buyers.
If you're generating at least $500K in EBITDA and have built a multi-provider model where revenue isn't concentrated in one physician, you likely fit the profile that attracts serious private equity interest.
Most dermatology practice sales take 4-6 months from engagement to closing, though timelines vary based on practice complexity and financial readiness. We move efficiently because you don't have patience for drawn-out processes.
The process includes initial preparation and valuation (2-3 weeks), confidential marketing to qualified buyers (4-6 weeks), offer evaluation and negotiation (2-3 weeks), due diligence (6-8 weeks), and closing (2-4 weeks). Practices with organized financials, strong EBITDA, and stable provider teams move faster.
Mohs surgery practices and multi-location groups may require longer transition planning, which is why we build realistic timelines and transition support into deal structures from the start.
Discover what your dermatology practice is worth
Whether you're evaluating an unsolicited offer or just exploring your options, understanding your actual practice value is essential. Use our custom calculator to get a realistic estimate in less than five minutes.